Table 1: Age and gender distribution of seroprevalence of SARS-CoV-2 antibody among study participants
|
Variable |
Antibody Rate |
|||
|
Total |
Positive (%) |
χ2 |
P |
|
|
Age group |
|
|
|
|
|
≤ 19 |
194 |
133 (68.56%) |
|
|
|
20-29 |
405 |
253 (62.47) |
|
|
|
30-39 |
569 |
373 (65.56) |
|
|
|
40-49 |
512 |
323 (63.09) |
5.3995 |
0.494 |
|
50-59 |
346 |
220 (63.58) |
|
|
|
60-69 |
154 |
87 (56.49) |
|
|
|
≥ 70 |
64 |
42 (65.60) |
|
|
|
Total |
2,244 |
1,431 (63.77) |
|
|
|
Sex |
|
|
|
|
|
Female |
1,073 |
684 (63.56) |
|
|
|
Male |
1,171 |
747 (63.62) |
0.0000 |
0.999 |
|
Total |
2,244 |
1,431 (63.77) |
|
|